Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

HIV Treatment Programs in Poor Countries as Effective as in Developed Countries

13.06.2005


Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.



Some have raised doubts that countries with extremely limited health care resources can effectively manage the complexities of antiretroviral therapy. But the new review of 10 medical studies on HIV treatment programs in the developing world showed that about 57 percent of patients had an undetectable level of HIV in their blood one year after starting ART, which is comparable to that in the developed world.

Availability and cost of ART medications are often barriers to treatment of HIV-infected people in countries lacking resources. Some countries, like Botswana, have government-funded ART programs that provide free or low-cost treatment to those in need. The article found that cost of medication was a significant factor--six months after ART initiation, nearly 30 percent more patients had undetectable viral levels when they received the drugs at no cost than did those who had to pay.


Lead author Louise Ivers, MD, of Harvard Medical School, was not surprised by the similarities in ART’s efficacy in poorer countries to that in industrial nations. "People in developing countries have just as much incentive to get well as in rich countries," she said, adding that, if ART is free, patients’ adherence to medication is good. However, "in most poor countries the cost of antiretrovirals is really prohibitive" and "even people who can afford it for a few months may not be able to afford it in the long term," said Dr. Ivers. "This shows that we have to try to find a way to provide free antiretrovirals." She hopes that the results showing a link between free ART and successful treatment of HIV will encourage governments in resource-limited countries to fund antiretroviral clinics for those in need.

All studies included in the review had to meet certain criteria, such as having only adult HIV patients, in order to effectively compare them with each other. Dr. Ivers, who works with HIV-infected patients in Haiti, believes the article’s findings would be the same regardless of how many studies were included. "We actually looked at hundreds of studies," Dr. Ivers said, but only selected "the ones that might meet the rich countries’ definition of antiretroviral success." However, many of the smaller studies not included "gave narrative descriptions of patients that had done well or gained weight" due to antiretroviral use.

An accompanying editorial by Carlos del Rio, MD, and Frances Priddy, MD, of Emory University, echoed Dr. Ivers’ sentiments and emphasized that "as substantial resources become available for treatment in resource-poor countries we must not allow funding for prevention to diminish."

Steve Baragona | EurekAlert!
Further information:
http://www.idsociety.org

More articles from Health and Medicine:

nachricht Electrical 'switch' in brain's capillary network monitors activity and controls blood flow
27.03.2017 | Larner College of Medicine at the University of Vermont

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>